Morbidity and mortality in systolic heart failure also associated with raised serum neprilysin levels. Reply

Affiliations

¹ Cardiology Service and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
² Biochemistry Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
³ Cardiology Service and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain. Electronic address: abayesgenis@gmail.com.

Comment

Josep Lupón et al. Int J Cardiol. 2015.

. 2015 Jul 1:190:201.

doi: 10.1016/j.ijcard.2015.04.179. Epub 2015 Apr 23.

¹ Cardiology Service and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
² Biochemistry Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
³ Cardiology Service and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain. Electronic address: abayesgenis@gmail.com.

No abstract available

Keywords: Heart failure; Neprilysin.

Comment on

Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.
Bayés-Genís A, Barallat J, Galán A, de Antonio M, Domingo M, Zamora E, Urrutia A, Lupón J. Bayés-Genís A, et al. J Am Coll Cardiol. 2015 Feb 24;65(7):657-65. doi: 10.1016/j.jacc.2014.11.048. J Am Coll Cardiol. 2015. PMID: 25677426
Morbidity and mortality in systolic heart failure also associated with raised serum neprilysin levels.
Jolobe OM. Jolobe OM. Int J Cardiol. 2015;187:234. doi: 10.1016/j.ijcard.2015.03.257. Epub 2015 Mar 19. Int J Cardiol. 2015. PMID: 25846651 No abstract available.